underwritten

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment OptionCalidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option

SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…

5 days ago
Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public OfferingAchieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

June 26, 2025 23:43 ET  | Source: Achieve Life Sciences SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE)…

2 months ago